Home   Business   Life Science

Life Science




Cancer Research UK to fund clinical trial of Bicycle Therapeutics immuno-oncology candidate

Cancer Research UK to fund clinical trial of Bicycle Therapeutics immuno-oncology candidate

Cancer Research UK to fund clinical trial of Bicycle Therapeutics immuno-oncology candidate

CRUK suggests the molecule could offer improved anti-tumor activity with fewer side effects compared to antibody-based approaches.


Cambridge Design Partnership works on new robotic surgery system with Titan Medical

Cambridge Design Partnership works on new robotic surgery system with Titan Medical

Cambridge Design Partnership works on new robotic surgery system with Titan Medical

A rival to CMR Surgical’s Versius, the SPORT system is focused on using single incisions.


Illumina’s $1.2bn acquisition of Pacific Biosciences called off

Illumina’s $1.2bn acquisition of Pacific Biosciences called off

Illumina’s $1.2bn acquisition of Pacific Biosciences called off

The sequencing companies were left frustrated by time taken for regulatory approval.


Astex Pharmaceuticals and Taiho Pharmaceutical sign cancer drug deal with Merck that could be worth $2.5billion

Astex Pharmaceuticals and Taiho Pharmaceutical sign cancer drug deal with Merck that could be worth $2.5billion

Astex Pharmaceuticals and Taiho Pharmaceutical sign cancer drug deal with Merck that could be worth $2.5billion

The Cambridge Science Park company and its sister firm will receive an upfront payment of $20million.


An interview with Mene Pangalos on his knighthood, the new AstraZeneca HQ and changing mindsets

An interview with Mene Pangalos on his knighthood, the new AstraZeneca HQ and changing mindsets

An interview with Mene Pangalos on his knighthood, the new AstraZeneca HQ and changing mindsets

‘I wasn’t particularly good at school,’ he admits.


Expedeon AG to rebrand as 4basebio and focus on DNA manufacture after Abcam concludes 120m euro deal

Expedeon AG to rebrand as 4basebio and focus on DNA manufacture after Abcam concludes 120m euro deal

Expedeon AG to rebrand as 4basebio and focus on DNA manufacture after Abcam concludes 120m euro deal

An interview with CEO Dr Heikki Lanckriet.


Mission Therapeutics confirms potential Alzheimer’s and Parkinson’s targets with AbbVie

Mission Therapeutics confirms potential Alzheimer’s and Parkinson’s targets with AbbVie

Mission Therapeutics confirms potential Alzheimer’s and Parkinson’s targets with AbbVie

Several enzymes have been identified under the collaboration.

3

Chinese Medical Systems to invest £25m by plugging into AstraZeneca and Cambridge Judge Business School life science networks

Chinese Medical Systems to invest £25m by plugging into AstraZeneca and Cambridge Judge Business School life science networks

Chinese Medical Systems to invest £25m by plugging into AstraZeneca and Cambridge Judge Business School life science networks

Chinese Medical Systems will offer seed investment capital in five-year programme.


Martin Frost: Why I’m standing down as CEO of CMR Surgical - and Per Vegard Nerseth is the right man to succeed me

Martin Frost: Why I’m standing down as CEO of CMR Surgical - and Per Vegard Nerseth is the right man to succeed me

Martin Frost: Why I’m standing down as CEO of CMR Surgical - and Per Vegard Nerseth is the right man to succeed me

He has led the robotics company from start-up to billion-dollar status and it is set to transform minimal access surgery.


Healx signs deal with Boehringer Ingelheim to aid fight against rare neurological diseases

Healx signs deal with Boehringer Ingelheim to aid fight against rare neurological diseases

Healx signs deal with Boehringer Ingelheim to aid fight against rare neurological diseases

The Cambridge company will use its Healnet AI platform to help identify new indications.


This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More